Zobrazeno 1 - 1
of 1
pro vyhledávání: '"A Fayet-Peret"'
PS-099 Pharmaceutical intervention: enoxaparin use recommendations in patients with renal impairment
Autor:
MA Castro-Vida, MJ Gimeno-Jorda, JE Martínez-de la Plata, A Fayet-Peret, Alba Martos-Rosa, Olivia Urquízar-Rodríguez, I Estepa-Moreno, J Urda-Romacho, Pedro José Acosta-Robles
Publikováno v:
European Journal of Hospital Pharmacy. 21:A183.2-A183
Background Enoxaparin is a low molecular weight heparin used in the treatment and prophylaxis of thromboembolic disease. It is metabolised in the liver and its elimination is mainly renal. Renal impairment results in a decrease in its elimination and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44d9fedb668c437b78a71d22bcdbfb16
https://doi.org/10.1136/ejhpharm-2013-000436.449
https://doi.org/10.1136/ejhpharm-2013-000436.449
